Cardiac SurgeryNCT05142176
Bilateral Erector Spinae Plane Block for Management of Acute Postoperative Pain After Pediatric Cardiac Surgeries Through a Midline Sternotomy
A study testing Erector spinae catheters insertion and Postoperative pain management in people with Cardiac Surgery, run by Tanta University.
Trial summary
Many analgesic modalities have been investigated in pediatrics. The analgesic efficacy of bilateral ultrasound-guided erector spinae plane block in pediatric patients undergoing open midline sternotomy will be examined. Read more about this study
- Who is it for?
- Ages 3 to 12 years
- Conditions the study is for
- Cardiac Surgery
- What is being tested?
- Erector spinae catheters insertion and Postoperative pain management
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 75 participants
- Where
- No sites listed yet
- Study dates
- 5 Feb 2022to 30 Mar 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 12 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- children undergoing cardiac surgical procedures through midline sternotomy
Who cannot join
- The patients with preoperative ejection fraction <35%
- allergic to the amide type of local anesthetics (LA)
- preoperative inotropic support
About this study
Many analgesic modalities have been investigated in pediatrics. The analgesic efficacy of bilateral ultrasound-guided erector spinae plane block in pediatric patients undergoing open midline sternotomy will be examined. Methods: 60 patients aged 3- 12 years will be randomly assigned into two groups: Control group will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Erector spinae plane block group will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. The postoperative pain was assessed using Modified Objective Pain Scores (MOPS) which will be evaluated at 0, 1, 2, 4, 6, 8, 10, and 12 hours after extubation, total consumption of intraoperative fentanyl (1µg/kg IV in case of inadequate analgesia), time to first rescue analgesic administration and postoperative paracetamol consumption will be recorded over the first 24 hours postoperatively.
Read the detailed description
75 children with an American Society of Anesthesiologists physical status class I and II undergoing cardiac surgical procedures through midline sternotomy . The patients with preoperative ejection fraction <35%, low-cardiac-output syndrome, recurrent ventricular arrhythmias, preoperative inotropic support, allergic to the amide type of local anesthetics (LA), requiring intubation for more than 3 hours or re-exploration, and requiring redo or emergency surgery will be excluded from the study. The enrolled children will be subsequently randomized into 2 groups using a computer generated random number table: Control group will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Erector spinae plane block group will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. The postoperative pain will be managed with rescue intravenous (IV) fentanyl. Both the groups will receive IV acetaminophen 15 mg/kg every 8 hours as a component of multimodal analgesia. A routine preoperative assessment will be performed for all the patients. Premedication in the form of 1 mg/kg promethazine syrup will be administered, 1 hour before shifting to the operating room. Standard American Society of Anesthesiologists monitoring will be instituted and the children were anesthetized as per institutional protocol. The protocol constituted an induction with sevoflurane in oxygen 50% and air, peripheral IV cannulation of appropriate size followed by IV midazolam, 0.05 to 0.1 mg/kg, fentanyl, l to 2 mg/kg, and rocuronium, 0.6 mg/kg, to facilitate endotracheal intubation. Femoral arterial access will be established for intra-arterial pressure monitoring. Central venous catheter will be inserted in the right internal jugular vein for central venous pressure monitoring in addition to the temperature, end-tidal carbon dioxide, and near infrared spectroscopy monitoring. Anesthesia will be maintained with sevoflurane (0.9-2%) in 50% oxygen in air mixture and supplemental boluses of 0.1 mg/kg of atracurium, with the hemodynamics maintained within 20% of the baseline. Ultrasound-Guided ESPB The ESPB will be performed with the child in a right lateral decubitus position under aseptic precautions. A high frequency (6-13 MHz) linear ultrasound transducer (Sonosite Inc, Bothell WA) was placed in a longitudinal orientation over the T3 transverse process lateral to the spinous process. After identifying the muscles (trapezius, rhomboid major, and erector spinae) above the hyperechoic transverse process image, a 5-cm 22- guage Stimuplex A block needle (B. Braun, Melsungen, Germany) will be inserted in-plane in a cephalo-caudad direction. The endpoint will be defined as the needle pointing to the tip of transverse process piercing the erector spinae muscle. The LA will be deposited at this position, close to the costotransverse foramen. The needle tip position will be confirmed by hydrolocation with 0.5 to 1 mL of 1% lidocaine indicating linear fluid spread lifting the fascial plane between the transverse process and erector spinae muscle. After careful negative aspiration, 1.5 mg/kg of 0.2% ropivacaine will be administered under ultrasound guidance . The process will be repeated with injection of 0.3 ml/kg bupivacaine 0.25%bupivacaine on the contralateral side adding up to a cumulative dose of 2 mg/kg ropivacaine. Following sternotomy, adequate heparinization will be achieved with a resultant activated clotting time >480 seconds before the initiation of cardiopulmonary bypass in both the groups. After a satisfactory surgical correction, the patient will be weaned off cardiopulmonary bypass followed by protamine administration. The patients will be transferred to the intensive care unit (ICU) after completion of the procedure.
Postoperative ICU Management and Postoperative Pain Assessment The electrocardiogram, invasive blood pressure, respiratory rate, and pulse oximetry (Spo2) were monitored and recorded throughout the postoperative period. The study subjects will be extubated within 2 to 3 hours postoperatively once the exubation criteria (conscious, hemodynamically stable, (peak inspiratory pressure) PIP <20 cmH2O above positive end-expiratory pressure (PEEP)will be fulfilled, no neuromuscular blockade, and normal arterial blood gas analysis). Postoperative pain assessment will be performed using Modified Objective Pain Score (MOPS)9 at 0, 1, 2, 4, 6, 8, 10, and12hours post extubation. Acetaminophen, 15 mg/kg, IV, every 8 hours will be administered in both the groups. . A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest. Postoperative adverse effects such as nausea, vomiting, cardiac arrhythmia, and complications such as LA toxicity, and vascular puncture were recorded and treated. Statistical Analysis Primary and Secondary Endpoints MOPS at 0, 1, 2, 4, 6, 8, 10, and 12 hours post extubation constituted the primary endpoints. The secondary endpoints will include intraoperative fentanyl requirement, extubation time, time to first rescue analgesic requirement, postoperative cumulative fentanyl requirement up to 12 hours, Ramsay sedation score, ICU stay, and incidence of adverse events.
- Conditions
- Cardiac Surgery
- Being tested
- Erector spinae catheters insertion, Postoperative pain management
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Erector spinae catheters insertionOther
Ultrasound-Guided ESPB The ESPB will be performed with the child in a right lateral decubitus position under aseptic precautions by a high frequency (6-13 MHz) linear ultrasound transducer
Postoperative pain managementDrug
IV acetaminophen 15 mg/kg every 8 hours as a component of multimodal analgesia.
| Study group | Role | What they receive |
|---|---|---|
| control group | Placebo comparator | will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Receives: Other: Erector spinae catheters insertion; Drug: Postoperative pain management |
| Erector spinae plane block group | Active comparator | will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. Receives: Other: Erector spinae catheters insertion; Drug: Postoperative pain management |
What is being measured
The primary outcome is the main question the study is designed to answer.
Modified Objective Pain Score (MOPS)0
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Measured: at immediately post extubation.
Modified Objective Pain Score (MOPS)1
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Measured: at1 hour post extubation.
Modified Objective Pain Score (MOPS)2
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Measured: at 2 hour post extubation.
Modified Objective Pain Score (MOPS)3
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Measured: at 4 hour post extubation.
Modified Objective Pain Score (MOPS)4
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Measured: at 6 hour post extubation.
Modified Objective Pain Score (MOPS)5
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Measured: at 8 hour post extubation.
Modified Objective Pain Score (MOPS)6
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Measured: at 12 hour post extubation.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Dec 2021
- Study start5 Feb 2022 (estimated)
- Primary completion30 Mar 2022 (estimated)
- Study completion30 Mar 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cardiac SurgeryStudies of the same condition, open and under way.
- More trials run by Tanta UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Bilateral erector spinae block
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 75 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mona Mohamed Mogahed, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05142176
- Sponsor's protocol ID
- 34774/7/21
- Status last verified
- Dec 2021
- First submitted
- 6 Nov 2021
- Last updated
- 1 Feb 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Feb 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Bilateral Erector Spinae Plane Block for Management of Acute Postoperative Pain After Pediatric Cardiac Surgeries Through a Midline Sternotomy
- ClinicalTrials.gov ID
- NCT05142176
- Acronym / sponsor ID
- 34774/7/21
- Conditions
- Cardiac Surgery
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 75 participants (estimated)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- 5 Feb 2022 (estimated)
- Primary completion
- 30 Mar 2022 (estimated)
- Study completion
- 30 Mar 2022 (estimated)
- First posted
- 2 Dec 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many analgesic modalities have been investigated in pediatrics. The analgesic efficacy of bilateral ultrasound-guided erector spinae plane block in pediatric patients undergoing open midline sternotomy will be examined. Methods: 60 patients aged 3- 12 years will be randomly assigned into two groups: Control group will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Erector spinae plane block group will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. The postoperative pain was assessed using Modified Objective Pain Scores (MOPS) which will be evaluated at 0, 1, 2, 4, 6, 8, 10, and 12 hours after extubation, total consumption of intraoperative fentanyl (1µg/kg IV in case of inadequate analgesia), time to first rescue analgesic administration and postoperative paracetamol consumption will be recorded over the first 24 hours postoperatively.
Detailed description
75 children with an American Society of Anesthesiologists physical status class I and II undergoing cardiac surgical procedures through midline sternotomy . The patients with preoperative ejection fraction <35%, low-cardiac-output syndrome, recurrent ventricular arrhythmias, preoperative inotropic support, allergic to the amide type of local anesthetics (LA), requiring intubation for more than 3 hours or re-exploration, and requiring redo or emergency surgery will be excluded from the study. The enrolled children will be subsequently randomized into 2 groups using a computer generated random number table: Control group will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Erector spinae plane block group will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. The postoperative pain will be managed with rescue intravenous (IV) fentanyl. Both the groups will receive IV acetaminophen 15 mg/kg every 8 hours as a component of multimodal analgesia. A routine preoperative assessment will be performed for all the patients. Premedication in the form of 1 mg/kg promethazine syrup will be administered, 1 hour before shifting to the operating room. Standard American Society of Anesthesiologists monitoring will be instituted and the children were anesthetized as per institutional protocol. The protocol constituted an induction with sevoflurane in oxygen 50% and air, peripheral IV cannulation of appropriate size followed by IV midazolam, 0.05 to 0.1 mg/kg, fentanyl, l to 2 mg/kg, and rocuronium, 0.6 mg/kg, to facilitate endotracheal intubation. Femoral arterial access will be established for intra-arterial pressure monitoring. Central venous catheter will be inserted in the right internal jugular vein for central venous pressure monitoring in addition to the temperature, end-tidal carbon dioxide, and near infrared spectroscopy monitoring. Anesthesia will be maintained with sevoflurane (0.9-2%) in 50% oxygen in air mixture and supplemental boluses of 0.1 mg/kg of atracurium, with the hemodynamics maintained within 20% of the baseline. Ultrasound-Guided ESPB The ESPB will be performed with the child in a right lateral decubitus position under aseptic precautions. A high frequency (6-13 MHz) linear ultrasound transducer (Sonosite Inc, Bothell WA) was placed in a longitudinal orientation over the T3 transverse process lateral to the spinous process. After identifying the muscles (trapezius, rhomboid major, and erector spinae) above the hyperechoic transverse process image, a 5-cm 22- guage Stimuplex A block needle (B. Braun, Melsungen, Germany) will be inserted in-plane in a cephalo-caudad direction. The endpoint will be defined as the needle pointing to the tip of transverse process piercing the erector spinae muscle. The LA will be deposited at this position, close to the costotransverse foramen. The needle tip position will be confirmed by hydrolocation with 0.5 to 1 mL of 1% lidocaine indicating linear fluid spread lifting the fascial plane between the transverse process and erector spinae muscle. After careful negative aspiration, 1.5 mg/kg of 0.2% ropivacaine will be administered under ultrasound guidance . The process will be repeated with injection of 0.3 ml/kg bupivacaine 0.25%bupivacaine on the contralateral side adding up to a cumulative dose of 2 mg/kg ropivacaine. Following sternotomy, adequate heparinization will be achieved with a resultant activated clotting time >480 seconds before the initiation of cardiopulmonary bypass in both the groups. After a satisfactory surgical correction, the patient will be weaned off cardiopulmonary bypass followed by protamine administration. The patients will be transferred to the intensive care unit (ICU) after completion of the procedure.
Postoperative ICU Management and Postoperative Pain Assessment The electrocardiogram, invasive blood pressure, respiratory rate, and pulse oximetry (Spo2) were monitored and recorded throughout the postoperative period. The study subjects will be extubated within 2 to 3 hours postoperatively once the exubation criteria (conscious, hemodynamically stable, (peak inspiratory pressure) PIP <20 cmH2O above positive end-expiratory pressure (PEEP)will be fulfilled, no neuromuscular blockade, and normal arterial blood gas analysis). Postoperative pain assessment will be performed using Modified Objective Pain Score (MOPS)9 at 0, 1, 2, 4, 6, 8, 10, and12hours post extubation. Acetaminophen, 15 mg/kg, IV, every 8 hours will be administered in both the groups. . A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest. Postoperative adverse effects such as nausea, vomiting, cardiac arrhythmia, and complications such as LA toxicity, and vascular puncture were recorded and treated. Statistical Analysis Primary and Secondary Endpoints MOPS at 0, 1, 2, 4, 6, 8, 10, and 12 hours post extubation constituted the primary endpoints. The secondary endpoints will include intraoperative fentanyl requirement, extubation time, time to first rescue analgesic requirement, postoperative cumulative fentanyl requirement up to 12 hours, Ramsay sedation score, ICU stay, and incidence of adverse events.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, care provider)
- Number of arms
- 2
- Model description
- Bilateral erector spinae block
| Arm | Type | Receives |
|---|---|---|
| control group | Placebo comparator | Other: Erector spinae catheters insertion, Drug: Postoperative pain managementwill receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. |
| Erector spinae plane block group | Active comparator | Other: Erector spinae catheters insertion, Drug: Postoperative pain managementwill receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. |
Who may qualify
- Ages
- 3 to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- children undergoing cardiac surgical procedures through midline sternotomy
Key exclusion criteria (3 listed)
- The patients with preoperative ejection fraction <35%
- allergic to the amide type of local anesthetics (LA)
- preoperative inotropic support
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Erector spinae catheters insertionUltrasound-Guided ESPB The ESPB will be performed with the child in a right lateral decubitus position under aseptic precautions by a high frequency (6-13 MHz) linear ultrasound transducer | Other | Erector spinae plane block group, control group |
| Postoperative pain managementIV acetaminophen 15 mg/kg every 8 hours as a component of multimodal analgesia. | Drug | Erector spinae plane block group, control group |
Primary outcome
Modified Objective Pain Score (MOPS)0
Time frame: at immediately post extubation.
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Modified Objective Pain Score (MOPS)1
Time frame: at1 hour post extubation.
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Modified Objective Pain Score (MOPS)2
Time frame: at 2 hour post extubation.
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Modified Objective Pain Score (MOPS)3
Time frame: at 4 hour post extubation.
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Modified Objective Pain Score (MOPS)4
Time frame: at 6 hour post extubation.
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Modified Objective Pain Score (MOPS)5
Time frame: at 8 hour post extubation.
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Modified Objective Pain Score (MOPS)6
Time frame: at 12 hour post extubation.
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Feb 2022.
Related trials for Cardiac Surgery
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
Not yet recruitingObservational study
Systematic Intraoperative Cell Salvage in On-Pump Cardiac Surgery Within a Mature Patient Blood Management Programme
Cardiac Surgical Procedures, Blood Transfusion
Recruiting
Change in Platelet Lipid Metabolism and Procoagulant Phenotype Induced by Cardiopulmonary Bypass. Impact on Postoperative Inflammatory Response and Bleeding Complications During Cardiac Surgery.
Cardiac Surgery, Cardiopulmonary Bypass
Not yet recruitingPhase 4
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Coronary Artery Disease, Coronary Artery Bypass Grafting
RecruitingObservational study
Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass Surgery
Coronary Artery Disease, Left Ventricular Systolic Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Erector spinae catheters insertion and Postoperative pain management in people with Cardiac Surgery, run by Tanta University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 1 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Modified Objective Pain Score (MOPS)0 (time frame: at immediately post extubation.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Feb 2022.